The nurse is educating a client with Paget's disease about the importance of calcium and vitamin D intake. What is the rationale for this education?

A potential complication of Paget's disease is an increased risk of bone fractures. The abnormal bone remodeling in Paget's disease weakens the bones, leading to an increased susceptibility to fractures.

a. Hypertension: Hypertension is not a direct complication of Paget's disease. The condition primarily affects bone structures.

c. Hypothyroidism: Hypothyroidism is not associated with Paget's disease. It is a separate condition related to thyroid gland dysfunction.

d. Kidney stones: While kidney stones may be unrelated to Paget's disease, they can be a complication of other conditions or metabolic disorders.

Monitoring serum calcium levels is important during bisphosphonate therapy for Paget's disease. Bisphosphonates can affect calcium metabolism, and monitoring calcium levels helps ensure appropriate dosing and prevent complications such as hypocalcemia or hypercalcemia.

a. Liver function tests (LFTs): Bisphosphonates generally do not have a significant impact on liver function. Monitoring LFTs is not a primary concern during bisphosphonate therapy.

c. Blood glucose levels: Bisphosphonate therapy is not known to affect blood glucose levels. Monitoring blood glucose is not directly related to Paget's disease treatment.

d. Complete blood count (CBC): Bisphosphonate therapy does not typically have a major effect on blood cell counts. Monitoring a CBC is not a primary concern during bisphosphonate treatment for Paget's disease.